GREY:IPHAF - Post by User
Comment by
MementoMorion Jul 18, 2008 10:57am
327 Views
Post# 15306240
RE: Similiar stage, totally different stock price?
RE: Similiar stage, totally different stock price?> Cardiome Corp, a very similar stage biotech company to ISA, its SP rocket rockets at Positive Phase II results! And its price is now over 11 dollars, 16 times higher than ISA's.
I don't know anything at all about Cardiome. You are certainly right that is valued much more highly than ISA, but I feel compelled to point out (not for the first time) that comparing share prices head to head is a completely meaningless exercise. Cardiome has 63.7 million shares; ISA has 106.2 million. If you want to compare valuations, compare their markets caps: $69 million for ISA versus $715 million for Cardiome. So Cardiome is valued about 10.4 times more than ISA. If Cardiome sits at $11 (and doesn't issue any new shares), ISA has to make it to $6.73 to be valued equally.